Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FOlfox6”

69 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 69 results

Testing effectiveness (Phase 2)Study completedNCT00625651
What this trial is testing

Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal CancerColon CancerColorectal Cancer+1 more
Amgen 202
Not applicableNot Yet RecruitingNCT07406126
What this trial is testing

Yttrium-90 Radioembolization Neoadjuvant Therapy With Immune Marker Profiling and Dosimetry for Potentially Resectable Patients With Colorectal Liver Metastases

Who this might be right for
Colorectal Liver Metastases (CRCLM)Unresectable Colorectal Liver Metastases
Fernando Gómez Muñoz 30
Testing effectiveness (Phase 2)Study completedNCT00819780
What this trial is testing

PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors

Who this might be right for
Colon CancerColorectal CancerRectal Cancer+1 more
Amgen 285
Testing effectiveness (Phase 2)Ended earlyNCT00881504
What this trial is testing

FOLFOX6 With Bevacizumab for Biliary System Carcinoma

Who this might be right for
Biliary Tract Cancer
Georgetown University 9
Testing effectiveness (Phase 2)Study completedNCT00865709
What this trial is testing

Study of Modified FOLFOX6 Plus or Minus Sorafenib in Stage IV Metastatic Colorectal Carcinoma (mCRC) Subjects

Who this might be right for
Metastatic Colorectal Cancer
Bayer 198
Testing effectiveness (Phase 2)UnknownNCT02887313
What this trial is testing

FOLFOX6 Totally Neoadjuvant Chemoradiation Therapy in Locally Advanced Rectal Cancer: A Real World Study

Who this might be right for
Rectal Cancer
Sun Yat-sen University 200
Large-scale testing (Phase 3)Ended earlyNCT00070122
What this trial is testing

Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumRecurrent Colon Cancer+5 more
National Cancer Institute (NCI) 2,200
Large-scale testing (Phase 3)WithdrawnNCT00735241
What this trial is testing

FOLFOX6 Plus Sir-Spheres Microspheres Plus Avastin in Patients With Nonresectable Liver Metastases From Colorectal Carcinoma

Who this might be right for
Colorectal CarcinomaLiver Metastases
Sirtex Medical
Testing effectiveness (Phase 2)Study completedNCT00286130
What this trial is testing

Safety and Efficacy of Folfox6 + Cetuximab Versus Folfiri +Cetuximab in Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Central European Cooperative Oncology Group 150
Testing effectiveness (Phase 2)UnknownNCT00594529
What this trial is testing

Feasibility Study of Neoadjuvant Chemotherapy Modified FOLFOX6 for Resectable Liver Metastases of Colorectal Cancers

Who this might be right for
Colorectal CancerLiver Metastasis
Kyoto University 27
Testing effectiveness (Phase 2)Study completedNCT01111604
What this trial is testing

Ramucirumab or Icrucumab in Colorectal Cancer

Who this might be right for
Colon CancerRectal Cancer
Eli Lilly and Company 158
Testing effectiveness (Phase 2)UnknownNCT00006115
What this trial is testing

Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Testing effectiveness (Phase 2)Study completedNCT00193219
What this trial is testing

Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colon Cancer
SCRI Development Innovations, LLC 36
Testing effectiveness (Phase 2)Study completedNCT01051167
What this trial is testing

Bi-weekly Cetuximab Combined With 5-fluorouracil/Leucovorin/Oxaliplatin (FOLFOX-6) in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Martin Schuler, Prof. Dr. med. 59
Early research (Phase 1)Study completedNCT01571024
What this trial is testing

BKM120 + mFOLFOX6 in Advanced Solid Tumors With Expansion Cohort Pancreatic Cancer

Who this might be right for
Advanced Solid TumorsMetastatic Colorectal CancerMetastatic Pancreatic Cancer
UNC Lineberger Comprehensive Cancer Center 17
Testing effectiveness (Phase 2)Study completedNCT01652196
What this trial is testing

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

Who this might be right for
Mucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the RectumSignet Ring Adenocarcinoma of the Colon+3 more
John Hays 56
Testing effectiveness (Phase 2)UnknownNCT03329183
What this trial is testing

High-dose FOLFIRI in Advanced Colorectal Cancer Patients With Wild-type UGT1A1*6 and *28

Who this might be right for
Colorectal Cancer
Shanghai Changzheng Hospital 90
Testing effectiveness (Phase 2)WithdrawnNCT00988897
What this trial is testing

Colorectal Cancer RECHALLENGE

Who this might be right for
Colorectal Neoplasms
Sanofi
Testing effectiveness (Phase 2)Study completedNCT02142322
What this trial is testing

Perioperative mFOLFOX-6 in Locally Advanced Gastric Cancer

Who this might be right for
Advanced Gastric Cancer
Seoul National University Hospital 52
Testing effectiveness (Phase 2)Study completedNCT00591123
What this trial is testing

Study of Erlotinib and Chemotherapy for Unresectable or Metastatic Cancer of the Esophagus and Gastric Cardia

Who this might be right for
Unresectable Adenocarcinoma of the EsophagusMetastatic Adenocarcinoma of the EsophagusUnresectable Adenocarcinoma of Gastric Cardia+1 more
Translational Oncology Research International 38
Next Page